ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01945775
Brief Title: A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study) (EMBRACA)

First Submitted : September 11, 2013
First Submitted that Met QC Criteria : September 16, 2013
First Posted : September 19, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : June 11, 2018
Last Update Posted : June 12, 2018